C

피플바이오

304840KOSDAQ의료용품 및 기타 의약 관련제품 제조업

53.6 / 100

Reference Date: 2026-06-10

Financial Score20.0 / 40
News Sentiment19.6 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but Revenue is on a declining trend. Plunged 26.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

PeopleBio is a biotech company specializing in the development of biomarker-based diagnostic technologies for early detection of Alzheimer's disease. The company's SI-MDS technology enables the detection of oligomeric beta-amyloid through blood tests, offering a cost-effective and efficient alternative to existing methods like PET or lumbar puncture. With rising demand for dementia diagnostics due to aging populations, the market is expected to grow significantly.

Number of Employees

43people

Average Salary

60.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
Industry Average 19.194.0Point
PBR
0.84Industry Average 1.305.5Point

Lower than industry avg (good)

ROE
-93.48Industry Average -4.893.5Point

19.1x industry avg (excellent)

Debt Ratio
6.75Industry Average 6.864.0Point

In line with industry avg

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼19.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲25.9% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -106.2% (improving, 3yr)

Detailed News Sentiment

6 totalPositive 5Neutral 1Negative 0Average Sentiment Score 78.3

Detailed Momentum

52-week position1.0Point

Near 52w low (15%, downtrend)

Current 990Won52-week high 2,68552-week low 671
1-month return0.0Point

1m -26.45% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

7 totalPositive 0Neutral 7Negative 0
  • Neutral주주명부폐쇄기간또는기준일설정2026-06-09
  • Neutral주식병합결정2026-06-09
  • Neutral주주총회소집결의 (임시주주총회)2026-06-09
  • Neutral본점소재지변경2026-05-19
  • Neutral분기보고서 (2026.03)2026-05-15